← Eichor
Study identifier: NCT05929820 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Impact of Protect Your Colon™ on CRC Screening

Condition: Colorectal Cancer Screening  ·  Sponsor: Cedars-Sinai Medical Center

PhaseNA
Planned participants184
Who can joinAll sexes, 45 Years to 75 Years
Healthy volunteersNo

About this study

The purpose of the research is to assess the impact of Protect Your Colon™, a colorectal cancer (CRC) screening decision aid, on patients' CRC screening behaviors. The Investigators hypothesize that Protect Your Colon™, through optimizing shared decision making, will lead to selection of a test that accurately matches patients' values and increase CRC screening uptake. To test this hypothesis, the investigators will conduct a pilot randomized controlled trial (RCT) to assess if provision of Protect Your Colon™ improves communication on CRC screening, intent to complete screening, and ultimately uptake of screening vs. usual care.

This description comes directly from the study's public registry record.

Talk to the study team

Christopher V Almario, MD, MSHPM  ·  310.423.4462  ·  Christopher.Almario@csmc.edu

Muskaan R Mehra, MS  ·  310.423.0715  ·  muskaan.mehra@cshs.org

Always discuss trial participation with your own doctor first.

Locations (1)

Cedars-Sinai Medical CenterLos Angeles, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05929820